Venous thromboembolism Trials in Padua, Italy
Conditions / Venous thromboembolism / Padua, Italy
Research into Venous thromboembolism spans multiple therapeutic approaches and trial phases.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02064439 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | COMPLETED | PHASE3 |
| NCT00439725 | Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study | COMPLETED | PHASE3 |
| NCT00679588 | Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery | COMPLETED | PHASE3 |
| NCT02832245 | Computerized Registry of Patients With Venous Thromboembolism (RIETE) | RECRUITING | — |
| NCT00361894 | Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. | COMPLETED | PHASE3 |
| NCT00986154 | Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). | COMPLETED | PHASE3 |
| NCT03045406 | Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer | COMPLETED | PHASE3 |
| NCT02234843 | EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis | COMPLETED | PHASE3 |
| NCT02303431 | Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study | COMPLETED | PHASE1 |
| NCT05171049 | A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | TERMINATED | PHASE3 |